As the Global Commercialization Lead, Friedreich's ataxia, you will be responsible for delivering the Disease Area Strategic Plan (DASP), working closely with regions to execute and evolve the global commercialization strategy, as we aim to launch in >50 markets globally. You will report to the Product Development and Commercialization Lead (PDC), Friedreich's ataxia, and will be a critical member of the global PDC team.
As SKYCLARYS expands into new geographies, you will be accountable for leading the cross-functional global brand strategy across marketing, Value & Access, medical, insights, forecasting, and advocacy and how it can best support the program’s continued growth. You will be a key strategic contributor to an integrated cross-functional team to develop and execute the disease area strategy, along with strategic priorities and assessing new business opportunities to enable sustainable market growth for the program.
What You’ll Do
Who You Are:
You are a strategic and entrepreneurial leader, high-impact, hands-on leader who enjoys and has experience integrating cross-functional considerations into leading commercialization strategic initiatives, team decisions, and work products. You appreciate learning from team members and other company partners and hearing multiple perspectives to inform recommendations and decisions. You have strong rare disease launch expertise, a deep understanding of how to partner cross-functionally, and bring this point-of-view to help drive key workstreams and communications. You are passionate about making a positive impact on the Rare Disease Community.
Qualifications
Required Skills
Preferred Skills:
Additional Information
Base salary offered is determined through an analytical approach utilizing a combination of factors including, but not limited to, relevant skills & experience, job location, and internal equity.
Regular employees are eligible to receive both short term and long-term incentives, including cash bonus and equity incentive opportunities, designed to reward recent achievements and recognize your future potential based on individual, business unit and company performance.
In addition to compensation, Biogen offers a full and highly competitive range of benefits designed to support our employees’ and their families physical, financial, emotional, and social well-being; including, but not limited to:
Why Biogen?
We are a global team with a commitment to excellence, and a pioneering spirit. As a mid-sized biotechnology company, we provide the stability and resources of a well-established business while fostering an environment where individual contributions make a significant impact. Our team encompasses some of the most talented and passionate achievers who have unparalleled opportunities for learning, growth, and expanding their skills. Above all, we work together to deliver life-changing medicines, with every role playing a vital part in our mission. Caring Deeply. Achieving Excellence. Changing Lives.
At Biogen, we are committed to building on our culture of inclusion and belonging that reflects the communities where we operate and the patients we serve. We know that diverse backgrounds, cultures, and perspectives make us a stronger and more innovative company, and we are focused on building teams where every employee feels empowered and inspired. Read on to learn more about our DE&I efforts.
All qualified applicants will receive consideration for employment without regard to sex, gender identity or expression, sexual orientation, marital status, race, color, national origin, ancestry, ethnicity, religion, age, veteran status, disability, genetic information or any other basis protected by federal, state or local law. Biogen is an E-Verify Employer in the United States.
Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities.
We apply deep understanding of human biology and leverage different modalities, to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth.
With approximately 7,000 people worldwide, we are truly a global organization, headquartered in Cambridge, Massachusetts, which is also home to our research operations. Our international headquarters are based in Baar, Switzerland and we have world-class manufacturing facilities in North Carolina and Solothurn, Switzerland. We offer therapies globally through direct affiliate presence in 30 countries and a network of distribution partners in over 50 additional countries.
For more information, please visit www.biogen.com. Community Guidelines: https://www.biogen.com/community-guidelines.html
Follow us on social media – LinkedIn, Facebook, X, and YouTube.
Take the next step in your career journey